TY - JOUR
T1 - Bibliometric Analysis of Botulinum Toxin and Bruxism
T2 - Impact, Visualization, and Collaborative Networks
AU - Villanueva-García, Marjorie
AU - Ruck-Sanchez, Nardy
AU - Tinedo-López, Pedro
AU - Espinoza-Carhuancho, Fran
AU - Pacheco-Mendoza, Josmel
AU - Mayta-Tovalino, Frank
N1 - Publisher Copyright:
© TheAuthor(s). 2024 Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
PY - 2024
Y1 - 2024
N2 - Aim: To analyze the scientific production related to the use of botulinum toxin (BTX-A) in the management of bruxism and evaluate its scope, impact, networks, and new research trends. Materials and methods: A descriptive and retrospective study of publications indexed in Scopus from January 2018 to May 2024 was conducted. The bibliometric indicators evaluated were a number of publications, citations, h-index, SCImago Journal Rank 2022, CiteScore 2022, Lotka’s Law, Bradford’s Law, and keyword co-occurrence analysis. Data were processed using SciVal and VOSviewer. Results: We obtained 98 publications, including original articles, reviews, and other types of documents. Among the most productive authors, most were from South Korea and Turkey. Wonkwang University (South Korea) had the highest number of publications, while Baylor College of Medicine (USA) had the highest impact with 66.5 citations per publication. Toxins had the highest number of publications and the best Cite Score in 2022. Six main topics related to BTX-A in bruxism were identified, highlighting “reviews, ”“electromyography” and “controlled clinical trials”. Conclusions: The use of BTX-A for the treatment of bruxism has generated increasing interest and scientific output in recent years, especially in South Korea and Brazil. However, there is a disparity in the productivity of authors, with most authors presenting only one publication. Clinical significance: This study highlights the need for further research and collaborations to optimize clinical practice and better understand the efficacy and management of BTX-A for treating bruxism.
AB - Aim: To analyze the scientific production related to the use of botulinum toxin (BTX-A) in the management of bruxism and evaluate its scope, impact, networks, and new research trends. Materials and methods: A descriptive and retrospective study of publications indexed in Scopus from January 2018 to May 2024 was conducted. The bibliometric indicators evaluated were a number of publications, citations, h-index, SCImago Journal Rank 2022, CiteScore 2022, Lotka’s Law, Bradford’s Law, and keyword co-occurrence analysis. Data were processed using SciVal and VOSviewer. Results: We obtained 98 publications, including original articles, reviews, and other types of documents. Among the most productive authors, most were from South Korea and Turkey. Wonkwang University (South Korea) had the highest number of publications, while Baylor College of Medicine (USA) had the highest impact with 66.5 citations per publication. Toxins had the highest number of publications and the best Cite Score in 2022. Six main topics related to BTX-A in bruxism were identified, highlighting “reviews, ”“electromyography” and “controlled clinical trials”. Conclusions: The use of BTX-A for the treatment of bruxism has generated increasing interest and scientific output in recent years, especially in South Korea and Brazil. However, there is a disparity in the productivity of authors, with most authors presenting only one publication. Clinical significance: This study highlights the need for further research and collaborations to optimize clinical practice and better understand the efficacy and management of BTX-A for treating bruxism.
KW - Bibliometric analysis
KW - Botulinum toxin
KW - Bruxism
UR - http://www.scopus.com/inward/record.url?scp=85205229458&partnerID=8YFLogxK
U2 - 10.5005/jp-journals-10024-3708
DO - 10.5005/jp-journals-10024-3708
M3 - Artículo de revisión
AN - SCOPUS:85205229458
SN - 1526-3711
VL - 25
SP - 599
EP - 604
JO - Journal of Contemporary Dental Practice
JF - Journal of Contemporary Dental Practice
IS - 6
ER -